Navigation Links
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Date:4/8/2011

among others, risks and timing associated with preclinical and clinical development of Regeneron's drug candidates, determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize its product and drug candidates, competing drugs that are superior to Regeneron's product and drug candidates, uncertainty of market acceptance of Regeneron's product and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any license or collaboration agreement, including Regeneron's agreements with the sanofi-aventis Group and Bayer HealthCare, to be canceled or terminated without any product success, and risks associated with third party intellectual property.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission (SEC), including its Form 10-K for the year ended December 31, 2010. Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.

Bayer Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management.  Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.  These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... The Assistance Fund announces the addition of ... assistance for copay to individuals diagnosed with Melanoma. ... of the Melanoma Copay Assistance Program to our portfolio ... director. "With each additional program we are closer to ... no one is denied access to medications due to ...
(Date:5/22/2015)... , May 22, 2015  The U.S. Food ... (filgrastim-sndz) -- the first biosimilar product approved in ... points toward growth in the contract manufacturing organization ... CMO industry is geared to the production of ... major biopharmaceutical products. The healthcare market research publisher,s ...
(Date:5/22/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) has announced ... Application Dossiers for Oversea Medical device registration and ... to their offering. The Chinese medical ... the most growth potentiality, which is attracting more ... to penetrate such market. It is estimated that ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... JERUSALEM, Jan. 11 IDenta Corp. (PinkSheets: IDTA) announced today ... a General Screening Explosive Identifier. , This kit has been ... ampoules it contains, the following substances can be identified with ... Identifier.. , Ampoule 1: TNT, DNT, Tetryl. , Ampoule ...
... LAGUNA BEACH, California, January 11 Advanced ... announced today that it has completed a $5 million ,Series,B, ... venture,capital firm specialized in medical technology investments, and is expected,to ... was founded in 2007 to develop a novel irrigated radiofrequency,cardiac ...
Cached Medicine Technology:International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 2International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 3Advanced Cardiac Therapeutics Completes $5 Million Financing 2Advanced Cardiac Therapeutics Completes $5 Million Financing 3
(Date:5/26/2015)... 26, 2015 Writers and editors ... the Vasont® CCMS to make creating, editing, and ... top component content management system (CCMS) software provider, ... supports oXygen XML Editor Version 17.0, Syncro Soft’s ... Integrator extension merges key editorial functionality of the ...
(Date:5/26/2015)... Denver, Colorado (PRWEB) May 26, 2015 ... cannabis industry expands and evolves, it is also experiencing ... businesses. And like their mainstream counterparts, one major issue ... how to recycle the tons of paper and plastic ... year. , “Where others see waste we see the ...
(Date:5/26/2015)... Many sexy cocktail dresses inspired ... dress collections recently. Now, TheCelebrityDresses.com is offering great ... to 70% off. The company aims to help ... hundreds of dollars on valuable, trendy formal outfits. ... carpet fashion special occasion dresses. Their dresses are ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Foot ... Dr. Enzo J. Leone (Pasadena and Baltimore ... as the Maryland Podiatric Medical Association (MPMA) President from ... Dr. Leone received his Doctorate in Podiatric Medicine from ... the West Jersey Hospital in Voorhees, New Jersey. ...
(Date:5/26/2015)... Pacifica Graduate Institute ... Day weekend, celebrating the outstanding accomplishments of its ... Ladera Lane campus, located in the Santa Barbara ... to Santa Barbara from all over the globe ... The 2015 commencement ceremonies featured the traditional Pacifica ...
Breaking Medicine News(10 mins):Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3
... those who received blood that was 29 days or older ... -- Hospital patients who receive a transfusion of stored blood ... for developing one or more serious infections compared to those ... authors pointed out that current U.S. regulations set the upper ...
... of candy, ST. LOUIS, Oct. 28 The ... year, and a sizeable portion of that indulgence,is eaten ... will,simply create an expanded beltline. However, for the more ... can pose more,tricky consequences., To help ease candy ...
... Californians are Provided With Resources to Prevent Millions in ... More than 97 million(1),cases of the flu are reported ... caused by missed work days. QuickHealth meets,the challenge by ... -- in language -- to clarify treatment options and ...
... Not Just a Nicety; Vacations are a Necessity, ... that the,long-term benefits associated with taking regular vacations ... fact, the statistics,are astounding. Men who don,t vacation ... heart attacks; women are 50 percent more likely.(1) ...
... at NanoBio Corporation have demonstrated for the first time ... sores (herpes labialis), NB-001, speeds healing of lesions as ... safety or toxicity concerns. , The new data provide ... can attain equivalent efficacy rates to oral systemic drugs, ...
... Ore., Oct. 28 Wellsource, Inc. of Portland,Oregon ... Solutions Ltd. of,Sheboygan, Wisconsin to form a new ... best of the family-owned companies to provide,full-service solutions ... and,future Wellsource and Health Solutions clients. Customers and ...
Cached Medicine News:Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 2Health News:Older Blood Boosts Chances of Infection in Transfusion Patients 3Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 2Health News:Orthodontists Offer Sweet Incentives for Tricky Halloween Treats 3Health News:75 Million Missed Work Days Expected This Flu Season 2Health News:75 Million Missed Work Days Expected This Flu Season 3Health News:Video: Regular Vacations: Prescription for a Healthy Lifestyle 2Health News:Video: Regular Vacations: Prescription for a Healthy Lifestyle 3Health News:Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift 2Health News:Wellsource Partners With Health Solutions Ltd. to Form Best-in-Class Health and Wellness Solutions for Its Clients. 2Health News:Wellsource Partners With Health Solutions Ltd. to Form Best-in-Class Health and Wellness Solutions for Its Clients. 3
Panoramic styling that contours closely to the face and brow. Saddle bridge fits average to fuller noses. Adjustable temple hinge adjusts up or down, longer or shorter. Soft cushion behind ear for co...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
Qualcraft Radiation Readers, Carbon Glasses. Protect yourself and have close-vision clarity....
The Bronze Metalite Constructed of optical-grade steel with bronze electroplate. Fitted lead side shields that create a seal to the front of the lenses for increased scatter protection....
Medicine Products: